Healthcare Medical devices industry looks for consultative process and a transition roadmap for new regulations Updated : March 03, 2020 06:39 PM IST Kotadia, whose company was one of a large beneficiary of stent price caps, says India is well within India’s right to do price control of medical devices. While Krishnan of Medtronic said unilateral price controls can damage the whole balance of the industry and players, capping trade margins is a transparent way for price control. Kotadia says the Make in India program should talk about servicing global markets from India and not only focus on the local market. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.